American International Group, Inc. · AIG · FY2026 Q1 · Calendar Q2 2026
AIG Beats EPS Estimates on 18% Premium Growth, AI Underwriting Gains
AIG delivered a record Q1 FY2026, beating EPS estimates by 11.6% on 18% YoY net premium written growth. Underwriting profitability improved across all segments, with accident-year combined ratios under 90%. Strategic transactions including the Everest portfolio conversion, Convex whole-account quota share, and Amwins SPV contributed to premium growth and profit acceleration. The company is deploying a multi-agent AI underwriting platform in partnership with Palantir and Anthropic across eight lines of business, with measurable efficiency gains. Capital returns of $760 million and an 11% dividend increase underscore balance-sheet confidence, while the planned Corebridge exit in 2026 simplifies the corporate structure. However, revenue of $6.78B missed the $7.03B estimate by 3.6%, and the stock subsequently drifted 6.8% lower after an initial 5.3% post-earnings pop, suggesting the…
Company context
Snapshot as of publicationAmerican International Group, Inc. (AIG) is a global insurance provider, delivering a broad spectrum of insurance solutions to commercial, institutional, and individual clients across North America and worldwide. Its General Insurance division encompasses a wide range of coverages, including general liability, environmental protection, commercial auto liability, workers' compensation, casualty, and crisis management. This segment also covers property risks for commercial, industrial, and energy sectors, with further specialized offerings such as aerospace, political risk, trade credit, portfolio solutions, crop, and marine insurance policies. Additionally, AIG supplies professional liability coverage for various business operations and potential hazards, such as directors and officers (D&O), mergers and acquisitions (M&A), fidelity bonds, employment practices, fiduciary liability, cyber risk, kidnap and ransom, and errors and omissions (E&O) insurance.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jul 15, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Overweight | Neutral | Upgrade | Jul 9, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 8, 2026 |
| HSBC | Buy | Buy | Maintain | Jul 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 6, 2026 |
| TD Cowen | Hold | Hold | Maintain | Dec 16, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Nov 20, 2025 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 1, 2025 |
| Jefferies | Buy | Buy | Maintain | Apr 11, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 13, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 6, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 10, 2024 |
| Argus Research | Buy | Hold | Upgrade | Nov 21, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Feb 22, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Sep 12, 2022 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Feb 10, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | May 13, 2021 |
| CFRA | Buy | Hold | Upgrade | Aug 4, 2020 |
| William Blair | Market Perform | Outperform | Downgrade | May 6, 2020 |
| Autonomous Research | Outperform | Market Perform | Upgrade | Jan 8, 2020 |
| Compass Point | Buy | Buy | Maintain | May 7, 2019 |
| Argus | Hold | Buy | Downgrade | Feb 15, 2019 |
| Buckingham Research | Neutral | Underperform | Upgrade | Apr 27, 2018 |
| Buckingham | Neutral | Underperform | Upgrade | Apr 27, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Feb 9, 2018 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Aug 4, 2016 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Mar 30, 2016 |
| Janney Capital | Buy | Neutral | Upgrade | Mar 30, 2016 |
| FBR Capital | Market Perform | Market Perform | Maintain | Feb 26, 2016 |
| Standpoint Research | Buy | Hold | Upgrade | Jan 19, 2016 |
| Avondale Partners | Underperform | Market Perform | Downgrade | Nov 4, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 3, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 13, 2014 |
| Nomura | Neutral | Neutral | Maintain | Aug 5, 2014 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Mar 1, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $80.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Paul Newsome | $80 | $79 | -0.2% | Jul 15, 2026 |
| Mizuho Securities | Analyst unavailable | $89 | $79.62 | +11.0% | Jul 9, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $92 | $79.62 | +14.7% | Jul 9, 2026 |
| UBS | Analyst unavailable | $98 | $80.47 | +22.2% | Jul 8, 2026 |
| HSBC | Analyst unavailable | $88 | $79.39 | +9.7% | Jul 6, 2026 |
| Barclays | Alex Scott | $80 | $74.8 | -0.2% | May 1, 2026 |
| Morgan Stanley | Bob Huang | $83 | $76.84 | +3.5% | Mar 16, 2026 |
| UBS | Analyst unavailable | $92 | $79.07 | +14.7% | Feb 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $81 | $78.76 | +1.0% | Feb 17, 2026 |
| Mizuho Securities | Yaron Kinar | $86 | $78.27 | +7.2% | Feb 17, 2026 |
| Mizuho Securities | Analyst unavailable | $83 | $72.29 | +3.5% | Jan 14, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $77 | $72.29 | -4.0% | Jan 14, 2026 |
| Barclays | Analyst unavailable | $81 | $77.07 | +1.0% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $83 | $77.07 | +3.5% | Jan 7, 2026 |
| Piper Sandler | Analyst unavailable | $95 | $86.03 | +18.5% | Dec 22, 2025 |
| Mizuho Securities | Yaron Kinar | $84 | $86.3 | +4.7% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $88 | $77.28 | +9.7% | Dec 5, 2025 |
| RBC Capital | Rowland Mayor | $85 | $75.11 | +6.0% | Nov 24, 2025 |
| Goldman Sachs | Analyst unavailable | $84 | $75.18 | +4.7% | Nov 20, 2025 |
| Barclays | Analyst unavailable | $95 | $80.71 | +18.5% | Nov 5, 2025 |
| UBS | Brian Meredith | $94 | $84.05 | +17.2% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $84 | $83.4 | +4.7% | Oct 7, 2025 |
| Piper Sandler | Analyst unavailable | $88 | $79.64 | +9.7% | Oct 2, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $84 | $78.48 | +4.7% | Aug 12, 2025 |
| Wells Fargo | Elyse Greenspan | $82 | $83.05 | +2.2% | May 6, 2025 |
| Barclays | Alex Scott | $98 | $87.72 | +22.2% | Apr 2, 2025 |
| HSBC | Analyst unavailable | $93 | $81.31 | +16.0% | Mar 5, 2025 |
| CFRA | Catherine Seifert | $87 | $75.39 | +8.5% | Nov 5, 2024 |
| Jefferies | Yaron Kinar | $88 | $74.63 | +9.7% | Oct 9, 2024 |
| HSBC | Vikram Gandhi | $82 | $73.8 | +2.2% | Sep 24, 2024 |
| Barclays | Alex Scott | $90 | $76.69 | +12.2% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $82 | $79.23 | +2.2% | Aug 1, 2024 |
| Jefferies | Yaron Kinar | $90 | $74.57 | +12.2% | Jul 8, 2024 |
| Evercore ISI | David Motemaden | $78 | $74.49 | -2.7% | Jun 26, 2024 |
| Morgan Stanley | Bob Huang | $82 | $78.74 | +2.2% | May 16, 2024 |
| CFRA | Catherine Seifert | $90 | $78.74 | +12.2% | May 16, 2024 |
| HSBC | Vikram Gandhi | $86 | $79.44 | +7.2% | May 15, 2024 |
| BMO Capital | Michael Zaremski | $89 | $79.43 | +11.0% | May 13, 2024 |
| Piper Sandler | Paul Newsome | $89 | $72.99 | +11.0% | Apr 19, 2024 |
| BMO Capital | Michael Zaremski | $91 | $77.92 | +13.5% | Apr 8, 2024 |
| RBC Capital | Mark Dwelle | $87 | $76.62 | +8.5% | Apr 5, 2024 |
| BMO Capital | Michael Zaremski | $83 | $66.46 | +3.5% | Dec 19, 2023 |
| Bank of America Securities | Joshua Shanker | $63 | $56.55 | -21.4% | Oct 7, 2021 |
| J.P. Morgan | Jimmy Bhullar | $55 | $47.44 | -31.4% | Jul 1, 2021 |
| Credit Suisse | Andrew Kligerman | $50 | $49.21 | -37.7% | May 11, 2021 |
| Piper Sandler | Paul Newsome | $52 | $46.07 | -35.2% | Apr 12, 2021 |
Track every rating change on AIG the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow AIG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 FY2026 marked a sharp improvement in underwriting profitability, with combined ratios improving dramatically and accident-year ratios under 90% across all segments. Net premiums written grew 18% YoY, driven by commercial and personal lines. The Everest portfolio conversion and Convex quota share acquisition contributed meaningful premium and profit acceleration. AIG launched a multi-agentic AI underwriting platform with Palantir (Foundry) and Anthropic (Claude), achieving 30% faster quoting and 40% higher binding in Lexington middle-market property. Capital deployment included $760 million in returns and a fourth consecutive year of double-digit dividend growth, with the quarterly dividend raised 11% to $0.50 per share. The stock rose 5.3% in the session following the report on 2.2x baseline volume before drifting 6.8% lower over subsequent sessions.
Guidance delta
Management maintained prior guidance, expressing confidence in sustaining growth and profitability. The company reaffirmed its intention to complete the Corebridge divestiture in 2026, continue share repurchases and dividend growth, and selectively expand in middle-market E&S and commercial lines. No explicit upward or downward revision to forward financial targets was indicated in the available transcript analysis.
Key takeaways
- EPS of $2.11 beat the $1.89 consensus by 11.6%; revenue of $6.78B missed the $7.03B estimate by 3.6%
- Net premiums written grew 18% YoY across commercial and personal lines
- Accident-year combined ratios improved to under 90% across all segments
- AI underwriting platform (Palantir, Anthropic) delivered 30% quoting improvement and 40% binding increase in Lexington middle-market property
- $760M in capital returns; dividend raised 11% to $0.50/share, fourth consecutive year of double-digit growth
- Stock rose 5.3% post-print but subsequently drifted 6.8% lower
Management priorities
- Scale multi-agent AI solution across underwriting and claims functions
- Complete divestiture of remaining Corebridge stake in 2026
- Continue share repurchases and dividend growth
- Target selective growth in middle-market E&S and commercial lines
- Pursue partnerships with technology providers and capital managers (CVC, Onex)
Related earnings events
Financial ServicesSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T03:21:07.362136+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T03:21:07.359380+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.